Scientists have identified a compound found in cruciferous vegetables that can wipe out over 90 per cent of the sticky film behind dental plaque, an advance that may lead to new kinds of toothpaste ...
Centauri plans the progression of lead candidate, an immunotherapy based broad-spectrum antimicrobial, to a first in human clinical study in early 2026 CARB-X’s additional funding brings their ...
Centauri Therapeutics Limited ('Centauri'), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, announced today that ...
CARB-X provides an additional $5.1M to complete the non-clinical safety and efficacy studies with ABX-01 lead candidate Centauri plans the progression of lead candidate, an immunotherapy based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback